Sareum (SAR) Competitors GBX 21 -1.00 (-4.55%) As of 09/5/2025 11:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SAR vs. CHI, PHD, IGR, FEN, NMT, TSI, CGO, MYN, IDE, and EVGShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include CT UK High Income Trust (CHI), Proactis (PHD), IG Design Group (IGR), Frenkel Topping Group (FEN), Neometals (NMT), Two Shields Investments Plc (TSI.L) (TSI), Contango (CGO), Mayan Energy (MYN), IDE Group (IDE), and Evgen Pharma (EVG). These companies are all part of the "financial services" industry. Sareum vs. Its Competitors CT UK High Income Trust Proactis IG Design Group Frenkel Topping Group Neometals Two Shields Investments Plc (TSI.L) Contango Mayan Energy IDE Group Evgen Pharma CT UK High Income Trust (LON:CHI) and Sareum (LON:SAR) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Which has higher earnings & valuation, CHI or SAR? CT UK High Income Trust has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than CT UK High Income Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCT UK High Income Trust£14.56M8.12£11.22M£0.12829.27SareumN/AN/A-£5.28M-£0.03-807.69 Is CHI or SAR more profitable? CT UK High Income Trust has a net margin of 84.52% compared to Sareum's net margin of 0.00%. CT UK High Income Trust's return on equity of 10.59% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets CT UK High Income Trust84.52% 10.59% 6.32% Sareum N/A -270.25%-113.80% Do institutionals & insiders hold more shares of CHI or SAR? 7.1% of CT UK High Income Trust shares are held by institutional investors. 0.2% of CT UK High Income Trust shares are held by company insiders. Comparatively, 36.6% of Sareum shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to CHI or SAR? In the previous week, CT UK High Income Trust's average media sentiment score of 0.00 equaled Sareum'saverage media sentiment score. Company Overall Sentiment CT UK High Income Trust Neutral Sareum Neutral Which has more volatility and risk, CHI or SAR? CT UK High Income Trust has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Sareum has a beta of -1.08, indicating that its share price is 208% less volatile than the S&P 500. SummaryCT UK High Income Trust beats Sareum on 9 of the 10 factors compared between the two stocks. Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£28.44M£224.82M£5.83B£2.57BDividend Yield1.10%3.78%6.70%5.31%P/E Ratio-807.6943.3476.155,361.54Price / SalesN/A5,212.37562.6195,775.89Price / Cash11.3213.1936.9927.93Price / Book8.0587.2111.487.02Net Income-£5.28M-£90.99M£3.29B£5.89B7 Day Performance5.00%2.31%1.27%0.63%1 Month Performance26.13%16.11%7.94%56.35%1 Year Performance-25.80%534.18%62.94%175.09% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 21-4.5%N/A-30.0%£28.44MN/A-807.693,211Gap DownCHICT UK High Income TrustN/AGBX 106+1.0%N/A+11.0%£88.32M£13.28M1,060.00N/ADividend AnnouncementPHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516IGRIG Design Group2.5766 of 5 starsGBX 61+1.7%GBX 195+219.7%-70.6%£59.86M£655.48M2.073,092Gap DownFENFrenkel Topping GroupN/AGBX 47-1.1%N/A-5.4%£57.58M£34.56M54.76307NMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/ATSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053CGOContangoN/AGBX 0.85-2.9%N/A-25.9%£6.15MN/A-85.002,219Gap DownMYNMayan EnergyN/AN/AN/AN/A£5.28M-£3K-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010 Related Companies and Tools Related Companies CT UK High Income Trust Competitors Proactis Competitors IG Design Group Competitors Frenkel Topping Group Competitors Neometals Competitors Two Shields Investments Plc (TSI.L) Competitors Contango Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SAR) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredHamilton’s 100-to-1 tradePorter Stansberry has made a career out of bold calls that go against the mainstream narrative — from the 1998...Porter & Company | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
